{"id":"W4405229751","doi":"10.1093/bjd/ljae360.045","title":"P15 Evaluating risankizumab for moderate-to-severe plaque psoriasis: real-world outcomes from an international study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Ustekinumab; Psoriasis; Plaque psoriasis; Adalimumab; Adverse effect; Internal medicine; Randomized controlled trial; Severity of illness; Dermatology; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009942758,0.0006698833,0.0007513014,0.0005584006,0.0005642992,0.001371806,0.0005318262,0.0007402999,0.001910714],"category_scores_gemma":[0.01049355,0.0002165591,0.001584124,0.001578523,0.0007061418,0.0005949864,0.0008112925,0.0008599979,0.0004085762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001044624,"about_ca_system_score_gemma":0.001729072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005493949,"about_ca_topic_score_gemma":0.005255353,"domain_scores_codex":[0.9951665,0.002911252,0.0004672837,0.0004715455,0.0007381774,0.0002452127],"domain_scores_gemma":[0.9835143,0.003830336,0.006479903,0.001456997,0.003014458,0.001703888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05781754,0.004461475,0.871021,0.002823655,0.005293867,0.000600001,0.00156324,0.001083322,0.002008457,0.0004582035,0.004607017,0.04826222],"study_design_scores_gemma":[0.007910863,0.02306747,0.951502,0.0006712113,0.00431051,0.00101543,0.001264872,0.001184096,0.001411866,0.0001666304,0.007397591,0.00009753682],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881915,0.004061825,0.0009199328,0.0002755701,0.00004473471,0.0006084277,0.002951597,0.00001425861,0.00293211],"genre_scores_gemma":[0.9949444,0.0009880769,0.0005841982,0.0001470162,0.00008432321,0.0002864285,0.002776349,0.000007590674,0.0001815551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009942758,"threshold_uncertainty_score":0.05258292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04039434091804939,"score_gpt":0.3398024483013667,"score_spread":0.2994081073833174,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}